PRESS RELEASE | Euformatics partners with Appolon Bioteck to expand in the French market
Espoo, September 6th, 2023. Euformatics, a Finnish bioinformatics company that develops world-leading genomic data analysis tools, announced that it
CNV analysis with Euformatics Genomics Hub
Copy Number Variations (CNVs) refer to alterations in the DNA of a genome that result in cells having an abnormal number of copies of one or more
PRESS RELEASE | Euformatics expands in the Middle East in partnership with Zahrawi Medical Group for Bahrain, Oman and the UAE markets
Espoo, Finland, May 2023. Euformatics, a Finnish bioinformatics company that develops world-leading NGS interpretation and quality control tools,
Streamlining NGS Testing: A Modular Solution with Euformatics Genomics Hub
Automation is a critical component of NGS testing and Euformatics Genomics Hub is leading the way with innovative solutions. With an ever-increasing
PRESS RELEASE | Euformatics and ViennaLab join forces to develop a complete and efficient solution for species level classification of the human gut microbiome.
Espoo, Finland, March 2023. Research points out that microorganisms play a role in many aspects of human health. Consequently, more and more people
Webinar | Validating an NGS pipeline with concordance analysis
Go to recorded webinar. NGS (Next-Generation Sequencing) is a powerful technology that allows researchers to quickly and efficiently sequence
PRESS RELEASE | Euformatics, in partnership with ViennaLab Diagnostics and Oncompass Medicine, awarded a contract to research and develop an end-to-end liquid biopsy solution for eight leading European oncology centers
Espoo, Finland, February 2023. Euformatics, a global leader in NGS data quality control and variant interpretation, together with ViennaLab